-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Parkinson's disease (PD) is the second most common neurodegenerative disease, with an incidence of 1% in people over the age of 60
Although the underlying pathophysiology of this disease has not been fully established, some histopathological features have been well described, most notably the degeneration of dopamine-producing neurons in the parasubstantia nigra
The endocrine system has been shown to have neuroprotective functions, especially antioxidant and anti-inflammatory effects
THC has desirable analgesic, muscle relaxant and antiemetic properties, but also has tricky psychoactive effects
Additionally, it has been speculated that the antioxidant properties of cannabis may slow PD progression and improve PD symptoms
Preclinical studies have shown that activation of CB1 receptors can reduce dyskinesia in animal models of PD
Berzenn Urbia et al.
Compelling evidence was found to recommend the use of cannabis in PD patients
Potential benefits found in relieving PD-related tremor, anxiety, pain, improving sleep quality, and quality of life
Original source:
Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
Leave a comment here